Literature DB >> 24951133

Growth factor expression after lesion creation in the avascular zone of the meniscus: a quantitative PCR study in rabbits.

Miguel Ángel Ruiz Ibán1, Nerea Comellas Melero2, Javier Martinez-Botas3, Ana Ortiz4, Jorge Diaz Heredia5.   

Abstract

PURPOSE: To define the variations in the expression of 5 growth factor genes in meniscal tissue after a lesion is created in the avascular zone of the medial meniscus of the rabbit.
METHODS: A longitudinal lesion was created in the avascular zone of the anterior horn of the medial meniscus in 42 rabbits. Six animals were killed at 0, 1, 3, 7, 14, 21, and 120 days after lesion creation. Meniscal tissue from the avascular and vascular zones was harvested. A quantitative polymerase chain reaction analysis was performed to evaluate the expression levels of 5 different growth factors: vascular endothelial growth factor A (VEGF-A), insulin-like growth factor 1 (IGF-1), transforming growth factor β1 (TGF-β1), platelet-derived growth factor β (PDGF-β), and interleukin 1β.
RESULTS: The basal expression levels of all the growth factors studied were similar in the avascular and vascular zones. There was an increase in VEGF-A expression in the avascular zone on the 14th day, an increase in IGF-1 expression in the vascular zone on the 14th day, a decrease in PDGF-β expression in both zones in the first week, an increase in interleukin 1β expression in both zones on the first day, and a decrease in TGF-β1 expression in the vascular zone in the first week. At 120 days, the expression levels of all 5 growth factors returned to basal levels.
CONCLUSIONS: There are significant variations in the expression of the growth factors studied during the first weeks after meniscal lesion creation. The preinjury expression levels are similar in the avascular and vascular zones and are not significantly different from the basal levels 4 months after injury. CLINICAL RELEVANCE: This study identifies potential therapeutic molecular targets (VEGF-A, IGF-1, TGF-β1, and PDGF-β) that can be used in the treatment of meniscal tears.
Copyright © 2014 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24951133     DOI: 10.1016/j.arthro.2014.04.089

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  4 in total

1.  Platelet-derived growth factor-coated decellularized meniscus scaffold for integrative healing of meniscus tears.

Authors:  Kwang Il Lee; Merissa Olmer; Jihye Baek; Darryl D D'Lima; Martin K Lotz
Journal:  Acta Biomater       Date:  2018-06-14       Impact factor: 8.947

2.  Platelet-Rich Plasma Increases the Levels of Catabolic Molecules and Cellular Dedifferentiation in the Meniscus of a Rabbit Model.

Authors:  Hye-Rim Lee; Oog-Jin Shon; Se-Il Park; Han-Jun Kim; Sukyoung Kim; Myun-Whan Ahn; Sun Hee Do
Journal:  Int J Mol Sci       Date:  2016-01-16       Impact factor: 5.923

3.  Microarray analysis of the molecular mechanisms associated with age and body mass index in human meniscal injury.

Authors:  Peiyan Huang; Jun Gu; Junguo Wu; Lei Geng; Yang Hong; Siqun Wang; Minghai Wang
Journal:  Mol Med Rep       Date:  2018-11-21       Impact factor: 2.952

4.  Clinical evaluation of micro-fragmented adipose tissue as a treatment option for patients with meniscus tears with osteoarthritis: a prospective pilot study.

Authors:  Gerard A Malanga; Paul S Chirichella; Nathan S Hogaboom; Teresa Capella
Journal:  Int Orthop       Date:  2020-10-07       Impact factor: 3.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.